{"name":"Yaopharma Co., Ltd.","slug":"yaopharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"YP05002","genericName":"YP05002","slug":"yp05002","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"YP05002","genericName":"YP05002","slug":"yp05002","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNR29oNVYzNnBxQXRrdWtKT08yYXhqWUhMOVdFQWowaHRWeVlBSGxORC1QdDZ5RXlMTnBtSE1SdEVNX3FudlpRRHp0M2pUY1RtSVZOMmpycGRyQkRkSGx0aXJ4MG9QcTZCcU1YRXRVUmNmVE1ZN3Q4RWJNUW5SaEx6RHJ3cGh0RGd3T3NlbXdzcEprbFgtcV9YMk9rOVRSbDN3NkZyVXY0djhCWVpINlE?oc=5","date":"2026-01-06","type":"deal","source":"Pfizer","summary":"December Social Media Round-Up—2025 Highlights, YaoPharma Co., Ltd. Global Collaboration, and More - Pfizer","headline":"December Social Media Round-Up—2025 Highlights, YaoPharma Co., Ltd. Global Collaboration, and More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQanJmQktDZE1kWU5PRjdXc1gtbVhKMW9yYmltUmdteG43dU1MRC1KdFN0WDAtQUlwaTMzeGctTnZQVndFWEI0ZVZ1eU9Wc0JwMV9VTnVPd05zRFlKbGE3U2xqR0Qwc2hodFhlWEhVeEFMUkt2UTZYQVdNOElNY0pjWGxXazA5T1kzTGhMLTNuMk9CY2NYMEZHTHBDOFY2Skt2RkhGaE9QNFJEVHFRS1lvUUR3?oc=5","date":"2025-12-10","type":"deal","source":"BioSpectrum Asia","summary":"Yao Pharma licenses oral GLP-1R agonists to Pfizer for $1.93 B - BioSpectrum Asia","headline":"Yao Pharma licenses oral GLP-1R agonists to Pfizer for $1.93 B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNcjVITG1XZW1kMDVYRl8xcDl1ekQtRG8yRkhVRXQ5cnk1UUJ6OUR2QmpIZHNwdm44X3BXSDV5UjR3bHFiNlZZU3hzSHNQSXZudS1jdk9EMzFjWEUzNHVlRGs5bnVnaFRmWTdYS00zN2gtbXBQQUlDY0NmVW80QmxScDFrQzF0WFdjZWo3b2tuZ19QTm10ZU9pcGxEVVQ4RzNRWTRiOGZIWGZRRGRJQjNKM1ZDREpDSmNZaEpr?oc=5","date":"2025-12-10","type":"deal","source":"European Pharmaceutical Review","summary":"Pfizer boosts its obesity plans with $2bn GLP-1 YaoPharma deal - European Pharmaceutical Review","headline":"Pfizer boosts its obesity plans with $2bn GLP-1 YaoPharma deal","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-10","type":"deal","source":"South China Morning Post","summary":"China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer - South China Morning Post","headline":"China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPQm5iTktRUnBSOFJkTi0tOXRIQmdOT2RNMDRkeC1rMWlvX3g1Y05fa1Y2YnphSmZkamhJZG5qdHo3VXVyVmVSNk9tRDRybWRwM00yTllzNVFrOU9wOE9RdUh0Vks1WktkZ0JGU0Vpb0FUeWoxSmVpb3ExcDlBNGYydmJMX2xYdExxRUFsNXBjdWZBMTF0OVB6TnVhNUNEOFo2Y2FoYVBxeWV6cnhuYzVydVM4eXJTRTdmWmFHalBFQWN2ZFFCTUw1dW53?oc=5","date":"2025-12-09","type":"deal","source":"Reuters","summary":"Pfizer partners with YaoPharma to develop weight management drug - Reuters","headline":"Pfizer partners with YaoPharma to develop weight management drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOSjFjalBDX2E2ZXoyUmo5YXZaQThKeXhvUXBNMElJUHVjNTZWMGxlaHBqM0NuQ3FJN3piajlpZ1QyMm53d2w0eHhlUmNabVZHRjFtUERaWXVTaUtLV2cweDJSaE83ZGpOSV9kMmlQOVhwTzlZU0pKcUFWd1lmYTA5YjlyWUk4SUdpTGowWGVVQ0hYdWt0eXdyYmdjRk95RHd5Y0g0cWcyc0xOMGlxNUdkODJlTHl4OG9hZUxIMi1zYVF4N0ZrY0hYa2VGRGxkS0NHSGc?oc=5","date":"2025-12-09","type":"deal","source":"Business Wire","summary":"Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma - Business Wire","headline":"Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQb2JkSkItZnBjMDgxTzhwdlQ0OVV3VzNZZzlpX1VIMnRVR1I1M3p5ZDZSNlR3NkxrS0NvVU5hblEwUERRYnVZU0dGVGR6X24wT3B1NlMyYk90c3hseFhKdE5KdFlRbGpQalBaVy1OX0pLczQwcUd5V2RXcGtKcW9uSEtTSm0zcklZ?oc=5","date":"2025-12-09","type":"deal","source":"Yahoo Finance","summary":"Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement - Yahoo Finance","headline":"Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFAxaGFUR1JuclJXVUlqLTNJNm16YmREdjh4M1huNHlEcDZEeV9LMkcyTE1TdkllOWU2M28zRVNBYk9TMEh5d2dXWWYyUHFBMi1nczdIZ3A0bEdXQkJZa1lmSEhhM3ZCUS0xRlVIdXpZRUh6VDVnV25EMW9uRdIBgAFBVV95cUxOY3dpZHhJSWJDT1BPYUJwTG13Q1ptYlhPaWtoM3ZjSEozWTV6S3c3WDgtOFMzdlpKalNWUmJqdEtOQnJ1WTN2QzNmb2w4bExONVdPM19KR1NYUDRMYnBfM0lqd2xhUkdiR0p5NkNEUktxb3U3VmFhN09RTFBtbTNlVw?oc=5","date":"2025-12-09","type":"deal","source":"CNBC","summary":"Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill - CNBC","headline":"Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNNlZ6RXhBMWVkUU9JUmdPeGpJZXpfVkczSHVfWTlvVVA2eVZOaW5pbWZKTnFzMjN0dUh5YXlUeEZ4OTFnS2R5Wnk4bFpvamw4ME5rUS1hRTZ2T1hMRjJqUXJtYk1XY2ZIV0pyU2VhNVVkVkxlM295SW9WWjdUcGtrYzN0TXdjbGNwa0Y3bnhPbVZCVGhhYWZhSFpaV1djZjNxaVpPT3VFaWZBQQ?oc=5","date":"2025-12-09","type":"pipeline","source":"Fierce Biotech","summary":"Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug - Fierce Biotech","headline":"Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPdnlxbFpkWm8zQkVQNl82elUyRVVLTTl1dkRQYzlmQUZ2X2NVdlMwejYyaVQ1a1lUUVpzQ2xuWFptQ2RjRV82X2dsZklHUWE2eEU1cTNsUko3Z2N0dVE5ZEFMRkFiNUE2Q1JfWF9OaGZQcXpXcm5veE5mdXJ1WFVyMW5zS1NLTk15a0kzV2ZRTFNXVEt2OXZkUzdueUd5bE9EQlNIUGdYUU4yR05KWFFBa2FzamhJUQ?oc=5","date":"2025-12-09","type":"deal","source":"BioSpace","summary":"After Metsera Battle, Pfizer Heads to China for Another Obesity Deal Worth up to $1.9B - BioSpace","headline":"After Metsera Battle, Pfizer Heads to China for Another Obesity Deal Worth up to $1.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQSk1HSWlITDdrWEFQMGFCd016R25aNlllV0J0Nm1TWW9kNmx3SVFiQTYyOHZBclk2bzU2Q2NaTm95YlFpV1l1RHVVbzFfQ1FXZHJ1WDNrMms2WjNIeHA3ZmZFcmNBQkdmbGhQcDRBbGlBbGtNaFFfVlVkQWNNVFM2MjlUOHZuSHJqc2RWZGZUTkhkWXc?oc=5","date":"2025-12-09","type":"pipeline","source":"BioPharma Dive","summary":"Pfizer dips into China for another try at an obesity pill - BioPharma Dive","headline":"Pfizer dips into China for another try at an obesity pill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNVTNsVkpxSm9UZXpCZ1NpWUZVc2czTklRQmxRaWpMZGJFVU41ZFhkQkNvMUN3aEQtN2hLS3hRa2QxZDltd1pXUmpMeXpkWHRobTJnZ1FsLW1HYXhmRkM1NWtVU01kMVJtbXBJQlJQMVNhUFBFVWhxSzE4VGJPNUV2LVZVRXRpR19yMWJOQllFREhENjktZWxOSmNndzZUNkpLamNMQmhwYTNyU1FH?oc=5","date":"2025-06-02","type":"pipeline","source":"BioWorld News","summary":"Chongqing Pharmaceutical and Yaopharma describe new GLP-1R agonists - BioWorld News","headline":"Chongqing Pharmaceutical and Yaopharma describe new GLP-1R agonists","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}